Almac Group invests £16 million for expansion in pharmaceutical development capacity in Loughborough, England
Introduction:
Craigavon-based Almac Group has announced an £16 million investment to expand its formulation and analytical development services to meet ongoing client demand.
Features:
The company announced the successful conclusion to negotiations to operate a significant proportion of the 70-acre Charnwood Campus in Loughborough, England – a world-class science, technology and enterprise park. Specifically, Almac will occupy the formulation development and analytical testing facilities at the site which will complement existing development & GMP services offered from its Craigavon NI Headquarters.
The Charnwood facilities were originally designed and built by a global Pharma company as part of its in-house formulation development, clinical manufacturing & analytical testing capabilities. Almac has now commenced recommissioning of the facilities with operations focusing initially on expanding both non-potent and potent solid oral dose processing, creating approximately 180 new jobs in the next 5 years.
Specifications:
| Name | Almac Group |
| Location | Loughborough, England |
| Type | Expansion |
| Estimated Cost | £16 Million |
| Jobs | 180 Jobs |
